Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hypertension

Objective Oxidative stress has been implicated in the pathogenesis of hypertension and its complications through alterations in nitric oxide (NO) metabolism. This study was designed to investigate whether a relationship exists between phagocytic nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent superoxide anion (•O2−) production and NO generation in patients with essential hypertension. Methods Superoxide production was assayed by chemiluminescence under baseline and stimulated conditions on mononuclear cells obtained from hypertensives (n = 51) and normotensives (n = 43). NO production was evaluated by determining serum NO metabolites, nitrate plus nitrite (NOx). Results Although there were no differences in baseline •O2− production between normotensives and hypertensives, the •O2− production in phorbol myristate acetate (PMA)-stimulated mononuclear cells was increased (P < 0.05) in hypertensives compared with normotensives. The PMA-induced •O2− production was completely abolished by apocynin, a specific inhibitor of NADPH oxidase. Moreover, stimulation of •O2− production by angiotensin II and endothelin-1 was higher (P < 0.05) in cells from hypertensives than in cells from normotensives. In addition, diminished (P < 0.001) serum NOx was detected in hypertensives compared with normotensives. Interestingly, an inverse correlation (r = 0.493, P < 0.01) was found between •O2− production and NOx in hypertensives. Conclusions Generation of •O2− mainly dependent on NADPH oxidase is abnormally enhanced in stimulated mononuclear cells from hypertensives. It is suggested that this alteration could be involved in the diminished NO production observed in these patients.

[1]  Z. Ungvari,et al.  High Pressure Induces Superoxide Production in Isolated Arteries Via Protein Kinase C–Dependent Activation of NAD(P)H Oxidase , 2003, Circulation.

[2]  Steven M Holland,et al.  Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. , 2003, The Journal of clinical investigation.

[3]  R. Clempus,et al.  Vascular NAD(P)H oxidases: specific features, expression, and regulation. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[4]  D. Harrison,et al.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. , 2000, Circulation research.

[5]  E. Schiffrin,et al.  Inflammation and vascular hypertrophy induced by angiotensin II: role of NADPH oxidase-derived reactive oxygen species independently of blood pressure elevation? , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[6]  J. Paramo,et al.  Preliminary characterisation of the promoter of the human p22phox gene: identification of a new polymorphism associated with hypertension , 2003, FEBS letters.

[7]  R. Seifert,et al.  Regulation of the superoxide-forming NADPH oxidase of human neutrophils is not altered in essential hypertension. , 1991, Journal of hypertension.

[8]  G. Kojda,et al.  Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. , 1999, Cardiovascular research.

[9]  M. Jankowski,et al.  NAD(P)H Oxidase Mediates Angiotensin II–Induced Vascular Macrophage Infiltration and Medial Hypertrophy , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[10]  H. Baumgartner,et al.  Endothelial Dysfunction and Subendothelial Monocyte Macrophages in Hypertension: Effect of Angiotensin Converting Enzyme Inhibition , 1991, Hypertension.

[11]  G. Dusting.  Nitric oxide in cardiovascular disorders. , 1995, Journal of vascular research.

[12]  G. Zalba,et al.  Polymorphisms and Promoter Overactivity of the p22 phox Gene in Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats , 2001, Circulation research.

[13]  J. Mehta,et al.  Alterations in nitric oxide synthase activity, superoxide anion generation, and platelet aggregation in systemic hypertension, and effects of celiprolol. , 1994, The American journal of cardiology.

[14]  D. Postma,et al.  Apocynin inhibits peroxynitrite formation by murine macrophages , 2000, British journal of pharmacology.

[15]  L. Ng,et al.  Increased free radical production in hypertension due to increased expression of the NADPH oxidase subunit p22phox in lymphoblast cell lines , 2002, Journal of hypertension.

[16]  P. Vallance,et al.  Measurement of nitrite and nitrate levels in plasma and urine--what does this measure tell us about the activity of the endogenous nitric oxide system? , 1998, Current opinion in nephrology and hypertension.

[17]  D. Harrison,et al.  Endothelial Regulation of Vasomotion in ApoE-Deficient Mice: Implications for Interactions Between Peroxynitrite and Tetrahydrobiopterin , 2001, Circulation.

[18]  E. Schiffrin,et al.  c-Src Induces Phosphorylation and Translocation of p47phox: Role in Superoxide Generation by Angiotensin II in Human Vascular Smooth Muscle Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[19]  G. Burmester,et al.  Preactivated peripheral blood monocytes in patients with essential hypertension. , 1999, Hypertension.

[20]  J. Díez,et al.  Oxidative Stress in Arterial Hypertension: Role of NAD(P)H Oxidase , 2001, Hypertension.

[21]  C. Bereczki,et al.  Oxidative stress in juvenile essential hypertension , 2003, Journal of hypertension.

[22]  E. Jackson,et al.  Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study. , 1995, Hypertension.

[23]  J. Ménard,et al.  Interactive electronic teaching (ISIS): has the future started? , 1996, Journal of Human Hypertension.

[24]  E. Schiffrin,et al.  Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways , 2001, Journal of hypertension.

[25]  U. Das,et al.  Are free radicals involved in the pathobiology of human essential hypertension? , 1993, Free radical research communications.

[26]  L. Ng,et al.  NADPH Oxidase Activity in Preeclampsia With Immortalized Lymphoblasts Used as Models , 2003, Hypertension.

[27]  I. G. Fantus,et al.  High Glucose-suppressed Endothelin-1 Ca2+ Signaling via NADPH Oxidase and Diacylglycerol-sensitive Protein Kinase C Isozymes in Mesangial Cells* , 2003, Journal of Biological Chemistry.

[28]  S. Sela,et al.  Participation of peripheral polymorphonuclear leukocytes in the oxidative stress and inflammation in patients with essential hypertension. , 1997, American journal of hypertension.

[29]  K. Pritchard,et al.  Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R Henssge,et al.  Leukocyte responsiveness to substances that activate the respiratory burst is not altered in borderline and essential hypertension. , 1996, Journal of human hypertension.

[31]  Richard J. Johnson,et al.  Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. , 2002, American journal of physiology. Renal physiology.

[32]  Stephanie W. Watts,et al.  Endothelin-1 Increases Vascular Superoxide via EndothelinA–NADPH Oxidase Pathway in Low-Renin Hypertension , 2003, Circulation.

[33]  J. Stolk,et al.  Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. , 1994, American journal of respiratory cell and molecular biology.

[34]  U. Walter,et al.  Nebivolol Prevents Vascular NOS III Uncoupling in Experimental Hyperlipidemia and Inhibits NADPH Oxidase Activity in Inflammatory Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[35]  G. Burmester,et al.  Preactivated monocytes from hypertensive patients as a factor for atherosclerosis? , 2001, Atherosclerosis.

[36]  U. Walter,et al.  Effects of Angiotensin II Infusion on the Expression and Function of NAD(P)H Oxidase and Components of Nitric Oxide/cGMP Signaling , 2002, Circulation research.

[37]  A. Dorrance,et al.  NADH/NADPH Oxidase and Enhanced Superoxide Production in the Mineralocorticoid Hypertensive Rat , 2001, Hypertension.

[38]  P. Tsao,et al.  Mononuclear cell adherence to cultured endothelium is enhanced by hypertension and insulin resistance in healthy nondiabetic volunteers. , 1999, Circulation.

[39]  R. Jones,et al.  NADPH oxidase: a universal oxygen sensor? , 2000, Free radical biology & medicine.

[40]  K. Hilgers.  Monocytes/macrophages in hypertension , 2002, Journal of hypertension.

[41]  J. Díez,et al.  Vascular NADH/NADPH oxidase is involved in enhanced superoxide production in spontaneously hypertensive rats. , 2000, Hypertension.

[42]  D. Sorescu,et al.  NAD(P)H oxidase: role in cardiovascular biology and disease. , 2000, Circulation research.

[43]  D. Harrison,et al.  Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.

[44]  R. Berkow,et al.  Tyrosine-specific protein phosphorylation during activation of human neutrophils. , 1990, Blood.

[45]  B. Babior.  NADPH oxidase: an update. , 1999, Blood.

[46]  I. Fridovich,et al.  Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. , 2001, Circulation research.